Happy Holidays from Pharma Dollars and Sense

We're taking some much needed time off from our coverage of Pharma to celebrate the season with our loved ones. We want to sincerely thank you for your readership, your comments and your participation. Here are our highest rated articles from 2009:

• Pharma Dollars and Sense: Will principle based accounting improve financial reporting?
• Pharma Dollars and Sense: IFRS versus US GAAP
• Pharma Dollars and Sense: Canada to switch to IFRS by 2011

We'll be back in January with more coverage.

We wish you Happy Holidays!

Complimentary Webinar: Assessing the Impact of Healthcare Reform on the Business of Medicare: An Interview with Gorman Health Group

Space is limited.
Reserve your Webinar seat now at:
https://www1.gotomeeting.com/register/504426600
Mention Priority code: P1507W1BLOG

John Gorman, CEO, Gorman Health Group, along with Jean LeMasurier, Senior Vice President, Public Policy, Gorman Health Group will examine the current state of US healthcare reform, and its short and long term impact on Medicare plans including the financial, operational and strategic implications of the proposed bills.

Healthcare Investment & Transaction Summit, New York City - Early Bird Ends This Friday, December 11

IIR’s Healthcare Investment & Transaction Summit (HITS), now taking place on January 28-29, 2010 in New York City, is the deal-making industry event of the year! Join us today and be one of the many to benefit from the year’s most prestigious healthcare deal-making event. HITS brings together the industry’s financial giants, with buyers and sellers, and the brokers who connect them and the bankers to subsidize their deals. Deals are happening in healthcare, and those with creativity, patience, and capital are benefiting from the current economy. There is no doubt the time to act is upon us, and the place to hit the deal out of the park is HITS 2010!

Gain access to industry thought leaders, including:

AMBIENT HEALTHCARE INDIANA ORTHOPAEDIC HOSPITAL
AMERICAN HOSPICE INGENIX CONSULTING (United Healthcare)
APAX PARTNERS JRG VENTURES
BLUE CROSS BLUE SHIELD OF LINDEN LLC
CAMDEN PARTNERS MONROE CARELL JR. CHILDREN'S HOSPITAL
CAPITAL BLUECROSS NASHVILLE HEALTH CARE COUNCIL
CMS NATIONAL RENAL ALLIANCE
CITI ODYSSEY HEALTHCARE
DEUTSCHE BANK SECURITIES PASSPORT HEALTH COMMUNICATIONS, INC.
EXPERIAN PROSKAUER ROSE LLP
FAULTLINE VENTURES REHABCARE
GE CAPITAL RIVERSIDE PARTNERS
GENERAL ATLANTIC LLC SHATTUCK HAMMOND
GENERAL ATLANTIC PARTNERS SIGNATURE HOSPITAL CORPORATION
GOLDMAN SACHS SPECTRUM EQUITY INVESTORS
GREAT HILL PARTNERS STROUDWATER ASSOCIATES
HEALTH EVOLUTION PARTNERS BLUE CROSS BLUE SHIELD OF TENNESSEE (BCBST)
HOSPICE COMPASSUS THE CARLYLE GROUP
HOULIHAN LOKEY

Download the brochure and take a look at the all-star speaker list and agenda featuring this year’s most prominent industry issues! Visit our website for further program details at www.healthcaredealsummit.com.

Plus, be sure to register by this Friday, December 11, to save $200 off the standard rate!

We hope to see you in January in New York City!

Complimentary Webinar: Assessing the Impact of Healthcare Reform on the Business of Medicare: An Interview with Gorman Health Group

December 15, 2009

2-3PM EST

Space is limited.
Reserve your Webinar seat now at:
https://www1.gotomeeting.com/register/504426600

Mention Priority Code: P1507W1BLOG

John Gorman, CEO, Gorman Health Group, along with Jean LeMasurier, Senior Vice President, Public Policy, Gorman Health Group will examine the current state of US healthcare reform, and its short and long term impact on Medicare plans including the financial, operational and strategic implications of the proposed bills.

About the Speakers:

Jean D. LeMasurier
Senior Vice President for Public Policy
Gorman Health Group

Jean LeMasurier joined Gorman Health Group after a 30 year career with the Centers for Medicare and Medicaid Services (CMS). Jean provides strategic planning and consulting services to Medicare Advantage Health Plans, Medicare Part D Prescription Drug Plans, drug companies and employers on programs under the Medicare Modernization Act.
Her areas of focus include health policy and health care reform and advising plans and employers on retiree options. Engagements include analysis of Medicare market opportunities, strategic advice on CMS legislative and regulatory requirements, audits and gap analyses to assure implementation of regulatory compliant programs.
Jean is also engaged in policy analysis, public speaking and educational and training activities.
As a senior CMS career official, Jean was responsible for the leading the $40 billion Medicare Managed care programs for many years, including serving as the Director of Policy and the Acting Director/Deputy Director of Operations and Regulatory Oversight. Jean also served as a Senior Advisor in the Employer Operations and Policy Group which implemented the employer provisions of the Medicare Modernization Act.
Jean also worked as a professional staff member on the Senate Finance Subcommittee on Health.

John K. Gorman
Chief Executive Officer

John Gorman is CEO of Gorman Health Group, a company he founded in 1996 (under its predecessor name, Managed Care Compliance Solutions) to provide Medicare regulatory compliance advisory services to healthcare payers. Under John’s leadership, Gorman Health Group has since emerged to beco

After registering you will receive a confirmation email containing information about joining the Webinar.

System Requirements
PC-based attendees
Required: Windows® 2000, XP Home, XP Pro, 2003 Server, Vista

Macintosh®-based attendees
Required: Mac OS® X 10.4 (Tiger®) or newer

Health care reform: Private Insurers paying for federal lobbying

A recent article written by Zenei Cortez at the California Progress Report looks at how the current finances in the health care industry are being geared towards federal lobbying. In fact, the article state that the nation's top 13 private health insurers and their trade group, America's Health Insurance Plans (AHIP) spent nearly $23 million in federal lobbying to tilt reform in their direction. Cortez believes that the insurance industry is spending money that will go on to harm the American public in terms of higher profit for the private insurance companies while affecting the quality of care Americans receive due to the prices of health insurance. Do you agree with this article?

What do you foresee happening to the financial aspects of healthcare reform in terms of both the insured and the healthcare companies?